1,721,005 research outputs found
Biological agents in head and neck cancer
No full textSurvival of head and neck cancer (HNC) patients has not dramatically improved over the last 30 years, despite the advances in surgical techniques, chemotherapeutic agents and radiotherapy treatment planning and definition. Different studies in molecular biology of HNC have been carried out, providing useful results for clinical application. HNC usually includes malignant tumors arising from mucosa of the upper aerodigestive tract, from nasopharynx to larynx/trachea, while salivary gland and thyroid cancers are less frequently listed in this classification. In this review, we chose to provide a comprehensive review of the role of biological agents in head and neck subsites. Molecular characteristics and treatment-relevant signaling pathways will be briefly discussed along with the results of the more recent clinical studies that include biological agents
Palifermin in prevention of head and neck cancer radiation-induced mucositis : not yet a definitive word on safety and efficacy profile
No full textOptimizing approaches to head and neck cancer : metastatic head and neck cancer : new options
No full textHow many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?
No full text
TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)
No full textCisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience
No full textA NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC)
No full textSAMITAL IN PROPHYLAXIS OF CHEMO-RADIOTHERAPY (CT-RT) INDUCED MUCOSITIS IN HEAD AND NECK SQUAMOCELLULAR CANCER (HNSCC) PATIENTS (PTS): RESULTS OF A PROSPECTIVE MONOINSTITUTIONAL PHASE II TRIAL
No full text- …
